-
1
-
-
4444382796
-
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
-
DOI 10.1016/S0140-6736(04)17018-9, PII S0140673604170189
-
S. Yusuf, S. Hawken, S. Ounpuu INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952 (Pubitemid 39208455)
-
(2004)
Lancet
, vol.364
, Issue.9438
, pp. 937-952
-
-
Yusuf, P.S.1
Hawken, S.2
Ounpuu, S.3
Dans, T.4
Avezum, A.5
Lanas, F.6
McQueen, M.7
Budaj, A.8
Pais, P.9
Varigos, J.10
Lisheng, L.11
-
2
-
-
22544476866
-
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: A substudy of the COMMA trial
-
DOI 10.1093/eurheartj/ehi292
-
P. Theroux, P.W. Armstrong, and K.W. Mahaffey Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur Heart J 19 2005 1964 1970 (Pubitemid 41435718)
-
(2005)
European Heart Journal
, vol.26
, Issue.19
, pp. 1964-1970
-
-
Theroux, P.1
Armstrong, P.W.2
Mahaffey, K.W.3
Hochman, J.S.4
Malloy, K.J.5
Rollins, S.6
Nicolau, J.C.7
Lavoie, J.8
The, M.L.9
Burchenal, J.10
Granger, C.B.11
-
3
-
-
0035824178
-
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy
-
E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy JAMA 286 2001 2107 2113 (Pubitemid 34041595)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.17
, pp. 2107-2113
-
-
Lindmark, E.1
Diderholm, E.2
Wallentin, L.3
Siegbahn, A.4
-
4
-
-
1842587885
-
C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
-
DOI 10.1056/NEJMoa032804
-
J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397 (Pubitemid 38419992)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.14
, pp. 1387-1397
-
-
Danesh, J.1
Wheeler, J.G.2
Hirschfield, G.M.3
Eda, S.4
Eiriksdottir, G.5
Rumley, A.6
Lowe, G.D.O.7
Pepys, M.B.8
Gudnason, V.9
-
5
-
-
33847109797
-
Use and misuse of the receiver operating characteristic curve in risk prediction
-
DOI 10.1161/CIRCULATIONAHA.106.672402, PII 0000301720070220000018
-
N.R. Cook Use and misuse of the receiver operating characteristic curve in risk prediction Circulation 115 2007 928 935 (Pubitemid 46294733)
-
(2007)
Circulation
, vol.115
, Issue.7
, pp. 928-935
-
-
Cook, N.R.1
-
6
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
JUPITER Study Group
-
P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
7
-
-
67949124665
-
Testing the inflammatory hypothesis of atherothrombosis: Scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
-
P.M. Ridker Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT) J Thromb Haemost Suppl 1 2009 332 339
-
(2009)
J Thromb Haemost
, Issue.SUPPL. 1
, pp. 332-339
-
-
Ridker, P.M.1
-
8
-
-
0033535812
-
Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
-
DOI 10.1016/S0140-6736(99)04021-0
-
H. Tunstall-Pedoe, K. Kuulasmaa, M. Mahonen, H. Tolonen, E. Ruokokoski, and P. Amouyel Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations Monitoring trends and determinants in cardiovascular disease Lancet 353 1999 1547 1557 (Pubitemid 29219203)
-
(1999)
Lancet
, vol.353
, Issue.9164
, pp. 1547-1557
-
-
Tunstall-Pedoe, H.1
Kuulasmaa, K.2
Mahonen, M.3
Tolonen, H.4
Ruokokoski, E.5
Amouyel, P.6
-
9
-
-
0020072450
-
Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction
-
F.C. de Beer, C.R. Hind, K.M. Fox, R.M. Allan, A. Maseri, and M.B. Pepys Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction Br Heart J 47 1982 239 243 (Pubitemid 12179920)
-
(1982)
British Heart Journal
, vol.47
, Issue.3
, pp. 239-243
-
-
De Beer, F.C.1
Hind, C.R.K.2
Fox, K.M.3
-
10
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
DOI 10.1056/NEJM199704033361401
-
P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979 (Pubitemid 27152782)
-
(1997)
New England Journal of Medicine
, vol.336
, Issue.14
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.H.5
-
11
-
-
43249118045
-
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
-
J. Danesh, S. Kaptoge, and A.G. Mann Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review PLoS Med 5 2008 e78
-
(2008)
PLoS Med
, vol.5
, pp. 78
-
-
Danesh, J.1
Kaptoge, S.2
Mann, A.G.3
-
12
-
-
47149103896
-
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study
-
DOI 10.1016/S0140-6736(08)61076-4, PII S0140673608610764
-
M.J. McQueen, S. Hawken, X. Wang INTERHEART Study Investigators Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study Lancet 372 2008 224 233 (Pubitemid 351978112)
-
(2008)
The Lancet
, vol.372
, Issue.9634
, pp. 224-233
-
-
McQueen, M.J.1
Hawken, S.2
Wang, X.3
Ounpuu, S.4
Sniderman, A.5
Probstfield, J.6
Steyn, K.7
Sanderson, J.E.8
Hasani, M.9
Volkova, E.10
Kazmi, K.11
Yusuf, S.12
-
13
-
-
85101729518
-
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study
-
Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 200;358:202-633.
-
Lancet
, vol.200
, Issue.358
, pp. 202-633
-
-
Walldius, G.1
Jungner, I.2
Holme, I.3
Aastveit, A.H.4
Kolar, W.5
Steiner, E.6
-
14
-
-
51649092992
-
C-reactive protein and coronary heart disease: A critical review
-
J.P. Casas, T. Shah, A.D. Hingorani, J. Danesh, and M.B. Pepys C-reactive protein and coronary heart disease: a critical review J Intern Med 264 2008 295 314
-
(2008)
J Intern Med
, vol.264
, pp. 295-314
-
-
Casas, J.P.1
Shah, T.2
Hingorani, A.D.3
Danesh, J.4
Pepys, M.B.5
-
15
-
-
61549120401
-
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: Results from PROVE IT-TIMI 22
-
K.K. Ray, C.P. Cannon, R. Cairns, D.A. Morrow, P.M. Ridker, and E. Braunwald Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 Arterioscler Thromb Vasc Biol 29 2009 424 430
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 424-430
-
-
Ray, K.K.1
Cannon, C.P.2
Cairns, R.3
Morrow, D.A.4
Ridker, P.M.5
Braunwald, E.6
-
16
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
JUPITER Study Group 219520
-
P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 219520
-
(2008)
N Engl J Med
, vol.359
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
17
-
-
0027933081
-
The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
-
DOI 10.1056/NEJM199408183310701
-
G. Liuzzo, L.M. Biasucci, and J.R. Gallimore The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424 (Pubitemid 24247397)
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.7
, pp. 417-424
-
-
Liuzzo, G.1
Biasucci, L.M.2
Gallimore, J.R.3
Grillo, R.L.4
Rebuzzi, A.G.5
Pepys, M.B.6
Maseri, A.7
-
18
-
-
61949199214
-
States, rates and traits: Prognosis research and chronic stable angina
-
H. Hemingway States, rates and traits: prognosis research and chronic stable angina Heart 95 2009 439 440
-
(2009)
Heart
, vol.95
, pp. 439-440
-
-
Hemingway, H.1
|